SCARLET DIAL: Open Payments
NPI 1942463336 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 53 payments from 11 companies in 2025. Trend: 2023 $1,096 · 2024 $1,022 · 2025 $1,101
Food & beverage: $1,011Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $178 |
| Novo Nordisk Inc | 5 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $161 |
| Astellas Pharma US Inc | 4 | $145 |
| Sumitomo Pharma America, Inc. | 5 | $122 |
| PFIZER INC. | 4 | $82 |
| Lilly USA, LLC | 4 | $72 |
| Exact Sciences Corporation | 3 | $64 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $45 |
Products named: CAPLYTA, MYFEMBREE, QULIPTA, Ozempic, NURTEC ODT, Cologuard Collection Kit, Veozah, JOURNAVX.
Industry payments across NC — which companies pay providers there.
